Some analysts project a 12-month price target averaging , implying over 20% upside.
AI responses may include mistakes. For financial advice, consult a professional. Learn more Is CVS Health the Ultimate Value Stock to Buy Right Now?
: The acquisition of assets from bankrupt rival Rite Aid has added roughly 9 million new patients to its pharmacy network. Potential Risks to Consider should i buy cvs stock
: Ongoing antitrust scrutiny of pharmacy benefit managers (PBMs) and potential changes to Medicare Advantage rates remain key risks for the 2027 fiscal year.
CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights Some analysts project a 12-month price target averaging
: CVS offers a 3.4% dividend yield , which is more than double the S&P 500 average.
: While 2026 rates were better than feared, fluctuating Medicare reimbursement and higher medical utilization costs can squeeze insurance margins. Learn more Is CVS Health the Ultimate Value
: The stock trades at roughly 11x forward earnings , significantly below its historical average of 12-15x. Morningstar estimates a fair value of $97.00 .